Today is 2020-07-15

Trial search
Filter Options
Public title Scientific title Subject ID
Registration Status Registration number Secondary ID
       More Options

34 trials have been registered

Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR2000032915

A randomized controlled trial for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the mild and common type novel coronavirus pneumonia (COVID-19) patients whose nCoV Nucleic acid did not turn negative after treated by hydroxychloroquine and Abidor

Hongqi Hospital Affiliated to Mudangjiang Medical University

Interventional 2020/05/15
Historical Versions ChiCTR2000031782

A questionnaire investigation of hydroxychloroquine for its potential protective effect against novel coronavirus infection (COVID-19)

The 2nd Xiangya Hospital of Central South Uinvercity

Observational 2020/04/10
Historical Versions ChiCTR2000031204

A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)

Beijing you'an Hospital, Capital Medical University

Interventional 2020/03/24
Historical Versions ChiCTR2000031174

Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19)

Shanghai Public Health Clinical Center

Interventional 2020/03/23
Historical Versions ChiCTR2000030987

A Randomized Controlled Trial for Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (COVID-19)

Beijing Chao-yang Hospital, Capital Medical University

Interventional 2020/03/20
Historical Versions ChiCTR2000030718

Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19)

Zhongnan Hospital of Wuhan University

Interventional 2020/03/11
Historical Versions ChiCTR2000030417

Cancelled by the investigator Efficacy and safety of chloroquine phosphate inhalation combined with standard therapy in the treatment of novel coronavirus pneumonia (COVID-19)

Harbin infectious diseases hospital

Interventional 2020/03/01
Historical Versions ChiCTR2000030054

A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)

Zhongshan Hospital Affiliated to Xiamen University

Interventional 2020/02/22
Historical Versions ChiCTR2000030031

Cancelled by the investigator A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV

The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital)

Interventional 2020/02/21
Historical Versions ChiCTR2000029992

A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)

Zhongshan Hospital Affiliated to Xiamen University

Interventional 2020/02/18
First 1 2 3 4 Next Last